Illumina launches SpliceAI2 genomic AI model for rare disease variant interpretation
Illumina says SpliceAI2 found 17% more disease-relevant splice variants, but clinical use will require more than stronger AI prediction.
Pharma & Biotech
Pharma & Biotech
Illumina expands AI-powered multiomic strategy with launch of Connected Multiomics software platform
Illumina, Inc. has officially launched Connected Multiomics, a cloud-native software platform designed to unify and analyze complex biological data across multiple omic modalities including genomics, transcriptomics, proteomics, and spatial biology. The tool is now widely available after a year-long early access program involving over 40 research groups. Positioned as a user-friendly yet technically powerful analysis